Vanguard Personalized Indexing Management
CLYM icon

Vanguard Personalized Indexing Management’s Climb Bio CLYM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,204
Closed -$76.7K – 2350
2026
Q1 		$76.7K Buy
11,204
+77
+0.7% +$444 ﹤0.01% 1992
2025
Q4 		$44.5K Sell
11,127
-3,419
-24% -$8.21K ﹤0.01% 1894
2025
Q3 		$29.2K Buy
+14,546
New +$27K ﹤0.01% 1950
2025
Q2 		– Sell
-15,225
Closed -$18.6K – 2046
2025
Q1 		$18.6K Buy
+15,225
New +$24.7K ﹤0.01% 1780

Other funds holding CLYM

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Personalized Indexing Management's CLYM Position: Q2 2026 in Review

Vanguard Personalized Indexing Management sold out of Climb Bio (CLYM) in Q2 2026, closing a stake of 11,204 shares — an estimated $76.7K sold.

Vanguard Personalized Indexing Management first reported a position in CLYM in Q1 2025 and held it in 4 quarters. The position peaked at $76.7K in Q1 2026. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Vanguard Personalized Indexing Management reported no remaining Climb Bio position as of Q2 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 11,204 Climb Bio shares in Q2 2026, an estimated $76.7K.
  • Vanguard Personalized Indexing Management first reported a position in Climb Bio in Q1 2025 and held it in 4 quarters.
  • Vanguard Personalized Indexing Management's Climb Bio position peaked at $76.7K in Q1 2026.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.